ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Sarepta Therapeutics, Inc. (SRPT) shows an Average True Range (ATR) of 2.57 and an Enterprise Value of 12.63B. Its average trading volume over the past 3 months is 10.51M, indicating liquidity. These fundamental metrics provide insight into SRPT's underlying financial health and market activity.
Sarepta Therapeutics, Inc. (SRPT) technical indicators as of July 31, 2025: the SMA 20 is 0.67%, SMA 50 at -34.34%, and SMA 200 at -79.47%. The RSI 14 value is 44.29, suggesting its current momentum. These technical analysis signals help assess SRPT's price trends and potential future movements.
Sarepta Therapeutics, Inc. (SRPT) stock performance overview as of July 31, 2025: The 52-week high is $145 (currently -88.56% below), and the 52-week low is $10.42 (currently 60.83% above). Over the past year, SRPT's performance is -88.65%, compared to the S&P 500's 17.04% change.
According to market data, Sarepta Therapeutics, Inc. (SRPT) stock's recent performance metrics show that over the last month, SRPT is -2.05%, with a Year-to-Date (YTD) performance of -86.22%. Over the past year, the stock has seen a -88.65% change. These figures summarize SRPT's price movements across various periods, reflecting its historical returns.
According to current financial data, SRPT stock's P/E (TTM) ratio is -6.76, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for SRPT, including P/S (0.76), P/B (1.47), and P/FCF (-2.47), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.